ClostraBio, Inc.
  • Home
  • Product Solutions
  • Science
  • Team
  • Media
  • Careers
  • Contact

​MEDIA

News & Press Coverage
CRAIN'S CHICAGO BUSINESS
​
​
How a former 'part-time' CEO found a quicker time to market for a Chicago gut health startup
Published February 27, 2026

PRESS RELEASE
​
​
ClostraBio Fully Enrolls Placebo-Controlled Clinical Study of CLB101™, Expands Commercial Reach Through Distribution Partnership with Maypro
Released January 8, 2026

PRESS RELEASE
​
​​
Maypro Partners with ClostraBio to Launch CLB101™
Released November 12, 2025
Additional coverage: NutraIngredients USA 

PRESS RELEASE
​
​
ClostraBio Announces Commercial Launch with Designs for Health, Initiation of Clinical Study for CLB101™, and Participation in SupplySide Global
Released October 24, 2025

SUPPLYSIDE GLOBAL
​
​
Turning Science into Opportunity: ClostraBio's SupplySide Global Journey
Interview with ClostraBio's CEO Ritu Shah, Published October 1, 2025

PRESS RELEASE
​
​
Designs for Health Introduces Revolutionary Gut Health Supplement Anaerostipes Probiotic
Released September 24, 2025

PRESS RELEASE
​
​
ClostraBio Announces Key Milestones:  Board Appointment of Industry Veteran Scott Ravech and Publication of CLB101™ Safety Data
Released September 16, 2025

WHOLE FOODS MAGAZINE
​
​
'Biotics Trends Driving Demand in 2026
Published August 27, 2025, with quote from ClostraBio's Chief Science Officer Brian Meehan, PhD 

PRESS RELEASE
​
​
ClostraBio Gains Self-Affirmed GRAS Status for Next-Gen Probiotic Ingredient CLB101™
Released July 29, 2025
Additional coverage: NutraIngredients USA 

PRESS RELEASE
​
​
ClostraBio Gains INVENT Illinois Investment, Appoints New CSO, Announces Plans for First Product Launch in Summer 2025  
Released March 20, 2025
Additional coverage: Crain's Chicago Business 

PRESS RELEASE
​
​
ClostraBio Announces Breakthrough Publication Describing Targeted Delivery of Metabolite to Gastrointestinal Tract via Oral Nanoparticles; Appoints CEO 
Released January 24, 2023
Additional coverage: UChicago News 

PRESS RELEASE
​
​
ClostraBio Closes $4M Series A-1 Financing 
Released September 30, 2022
Additional coverage: Crain's Chicago Business 

AMERICAN CHEMICAL SOCIETY
​

Food Allergies Can be Reversed in Mice by Targeting the Microbiome 
Published August 21, 2022

PRESS RELEASE
​

​ClostraBio Will Present at 14th Annual Biotech Showcase Event 
Published January 10, 2022

WORLD BUSINESS CHICAGO
​

Meet Portal Innovations

Published February 25, 2021

PRESS RELEASE

​Portal Innovations Launching Lab Space at the Fulton Labs Campus One Year Ahead of Schedule
Released December 1, 2020
Additional coverage: Crain's Chicago Business

UCHICAGO POLSKY CENTER
​

ClostraBio co-founder, Prof. Jeffrey Hubbell, honored with "Hero of Medicine" award from Halo Cures
Released Sept 27, 2019

BIO 2019
​

ClostraBio announced as a winner of Startup-Stadium
Released July 1, 2019

PRESS RELEASE
​

ClostraBio announces $3.5 million Seed financing
Published Jan. 9, 2018
Additional coverage: ChicagoInno | Crain's Chicago Business | UChicago Polsky Center and UChicagoNews

CHICAGOINNO
​

ClostraBio named one of ChicagoInno's '18 Startups to Watch in 2018'
Published  Dec. 11, 2017

UCHICAGO POLSKY CENTER
​

University of Chicago Innovation Fund invests in ClostraBio
Published June 5, 2017

UCHICAGO POLSKY CENTER
​

ClostraBio takes 4th place in Chicago Booth New Venture Challenge, one of the U.S. top startup accelerators.
Published June 2, 2017

UCHICAGO NEWS
​

Sixteen advances in research and innovation in 2016
Published Jan. 24, 2017

​CBS NEWS

​Probiotics may help prevent peanut allergies, animal study shows

Published Aug. 26, 2014

BBC NEWS

Gut bugs 'Help Prevent Allergies'
Published Aug. 26, 2014

TIME MAGAZINE

The bacteria that may one day cure food allergies
Published Aug. 25, 2014
Publications
​A comprehensive toxicological safety evaluation of Anaerostipes caccae 
Peer-Reviewed Original Research Article in International Journal of Toxicology
Published Aug. 29, 2025

​A synbiotic of Anaerostipes caccae and lactulose prevents and treats food allergy in mice 
Peer-Reviewed Original Research Article in Cell Host & Microbe
Published Jul. 10, 2024

​Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles
Peer-Reviewed Original Research Article in Nature Biomedical Engineering
Published Dec. 22, 2022

Fecal Microbiome and Metabolome Differ in Healthy and Food-allergic Twins
Peer-Reviewed Literature Review in The Journal of Clinical Investigation
Published Jan. 19, 2021

The Microbiome and Food Allergy
Peer-Reviewed Literature Review in Annual Review of Immunology
Published April 2019

Healthy infants harbor intestinal bacteria that protect against food allergy
Peer-Reviewed Original Research Article in Nature Medicine
Published Jan. 14, 2019

The Microbiome, Timing, and Barrier Function in the Context of Allergic Disease
Peer-Reviewed Literature Review in Immunity
Published April 19, 2016

Lactobacillus rhamnosus GG-supplemented Formula Expands Butyrate-producing Bacterial Strains in Food Allergic Infants
Peer-Reviewed Original Research Article in The ISME Journal
Published Sept. 22, 2015

Commensal Bacteria Protect Against Food Allergen Sensitization
Peer-Reviewed Original Research Article in PNAS
Published Sept. 9, 2014
CONTACT US
©2026 ClostraBio
  • Home
  • Product Solutions
  • Science
  • Team
  • Media
  • Careers
  • Contact